Phosco Ltd Allocates 2 Million Shares to Key Executive via Approved Employee Incentive Plan

Shareholder-Sanctioned Incentive Award Drives 2 Million Share Issuance

The 2,000,000 ordinary shares issued by Phosco Ltd were not part of a capital raise or Placement to external investors. Instead, they fulfill an incentive award previously approved by shareholders at the company’s Annual General Meeting on 20 November 2025, specifically through Resolution 8, in compliance with ASX Listing Rule 10.14.

ASX Listing Rule 10.14 mandates that any securities issued to directors or other key management personnel under an employee incentive scheme require prior shareholder approval. Since this approval was obtained at the November 2025 AGM, the issuance on 2 July 2026 formalizes an entitlement already authorized by shareholders. The employee incentive scheme’s terms are documented in a filing lodged with ASX in October 2024, accessible via the exchange’s announcement platform.

Mehdi Ben Abdallah Confirmed as Sole Recipient of Incentive Shares

The company update identifies Mehdi Ben Abdallah as the exclusive recipient of the 2,000,000 shares, which are registered directly in his name. Mr Ben Abdallah is designated as key management personnel (KMP) within Phosco’s corporate framework, triggering specific disclosure requirements under ASX Listing Rules and the Corporations Act 2001.

The direct issuance to a named KMP, rather than through an intermediary, enhances transparency. Shareholders and analysts monitoring executive remuneration and insider equity stakes can now confirm that Mr Ben Abdallah holds 2,000,000 fully paid ordinary shares registered in his name. The company did not disclose Mr Ben Abdallah’s specific role or title in this update.

Issue Price Set in Euros at EUR 0.00050 Per Share

A notable aspect of this issuance is the issue price per share, disclosed as EUR 0.00050000 — equivalent to one-twentieth of one Euro cent. The use of Euros rather than Australian dollars is unusual for an ASX-listed company and may reflect Phosco’s international corporate structure or the original terms of the incentive award.

At this nominal price, the total cash consideration for the 2,000,000 shares amounts to EUR 1,000. The company did not provide an Australian dollar equivalent or further explanation regarding the Euro denomination. Investors seeking additional details should consult the employee incentive scheme documentation filed with ASX in October 2024.

Phosco’s Quoted Ordinary Shares Increase to 537,796,676

Following the quotation of these new shares, Phosco’s total quoted fully paid ordinary shares will be 537,796,676, as disclosed in the company’s capital structure statement accompanying the quotation application.

The 2,000,000 share addition to a base of approximately 535.8 million shares represents an incremental dilution of roughly 0.37%, a relatively minor impact on the company’s overall capital. Nevertheless, investors focused on dilution—especially in smaller-cap or exploration-stage companies—should note this updated share count for future capital management and Valuation Analysis.

Significant Unquoted Options and Potential for Future Dilution

Beyond quoted shares, Phosco’s capital structure includes a large number of unquoted securities convertible into ordinary shares. The most significant tranche comprises 150,000,000 options expiring 31 January 2028 with an exercise price of $0.05, trading under the code PHOAA. This tranche alone could represent a potential issuance equal to approximately 27.9% of the current quoted share count.

Additional unquoted securities include 18,265,634 options expiring 7 May 2027 at $0.05 (PHOAK), 10,000,000 options expiring 1 March 2028 at $0.18 (PHOAL), and 3,000,000 performance rights (PHOAC). If all options and performance rights vest and are exercised, the fully diluted share count would rise substantially. Investors should factor this potential dilution into their assessment of the company’s equity structure. The company did not provide guidance on the probability or timing of exercising these instruments.

ASX Listing Rule 10.14 Governs Key Management Personnel Share Issuances

This transaction is governed by ASX Listing Rule 10.14, which regulates the issuance of securities to directors, key management personnel, and their associates under employee incentive schemes. The rule ensures shareholders maintain oversight and approval rights over equity-based remuneration arrangements to mitigate conflicts of interest.

Phosco complied with this process by securing shareholder approval at the November 2025 AGM under Resolution 8. The company also invoked Listing Rule 7.2, Exception 14, which exempts this issuance from requiring additional shareholder approval under Listing Rule 7.1, which limits the volume of shares issuable without a vote. This approach aligns with standard compliance for share issuances pre-approved under Rule 10.14.

New Shares Have Equal Rights with Existing Ordinary Shares from Issue Date

Phosco confirmed that the 2,000,000 newly issued shares will rank equally in all respects with existing quoted ordinary shares from their issue date of 2 July 2026. This includes identical voting rights, dividend entitlements (if declared), and participation in any future capital returns.

Equal ranking from the issue date is standard for shares issued under such employee incentive schemes and grants the recipient full shareholder rights immediately. The company did not indicate any transfer restrictions on these shares, consistent with their classification as employee incentive securities without transfer limitations.

Employee Incentive Scheme Terms Detailed in October 2024 ASX Filing

The update references a document lodged with ASX in October 2024 outlining the terms of Phosco’s employee incentive scheme. This document governs the current issuance to Mr Ben Abdallah. Investors interested in the scheme’s full scope—including eligibility, vesting conditions, performance criteria, and maximum securities issuable—should refer to this publicly accessible filing.

The existence of a formally documented and previously disclosed scheme reflects positively on governance, demonstrating that the company established and communicated the framework before issuing awards. The current quotation application for the 2,000,000 shares represents the final administrative step in executing a shareholder-approved award governed by this scheme.

Investor Considerations Following Phosco’s Capital Structure Update

Investors monitoring Phosco’s equity should watch for further issuances under the employee incentive scheme, particularly the 3,000,000 outstanding performance rights (PHOAC). Performance rights typically vest upon meeting operational or financial milestones, and their conversion announcements would increase the quoted share count.

Beyond capital structure changes, near-term catalysts for Phosco are likely tied to core operational developments, which were not covered in this update. The immediate share price impact of this issuance was not disclosed. Investors following PHO should also consider the substantial options overhang, especially the 150,000,000 options exercisable at $0.05 expiring in January 2028, which pose a significant contingent dilution risk depending on the company’s share price trajectory over the next 18 months.